Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,271 public trials 1,197 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, not recruiting

Study of Novel Treatment Combinations in Patients With Lung Cancer

NCT05633667

Conditions
Advanced or Metastatic Non-Small-Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations
  • Arizona Oncology Associates,Substudy-02 Tucson, Arizona, United States
  • Fort Wayne Medical Oncology and Hematology, Inc.,Substudy-03 Fort Wayne, Indiana, United States
  • Baptist Health Lexington,Substudy-03 Lexington, Kentucky, United States
  • Washington University School of Medicine - Siteman Cancer Center,Substudy-01 St Louis, Missouri, United States
View all 89 locations
View Trial Details
Active, not recruiting

Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer

NCT04736173

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Research Site Columbus, Georgia, United States
  • Research Site Kingwood, Texas, United States
  • Research Site Blacksburg, Virginia, United States
  • Research Site Hong Kong
View all 39 locations
View Trial Details
Active, not recruiting

Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)

NCT04938817

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0152) Gilbert, Arizona, United States
  • Northside Hospital-Northside Hospital Oncology Network ( Site 0156) Atlanta, Georgia, United States
  • Parkview Research Center at Parkview Regional Medical Center ( Site 0180) Fort Wayne, Indiana, United States
  • Baptist Health Lexington-Research ( Site 0158) Lexington, Kentucky, United States
View all 48 locations
View Trial Details
Active, not recruiting

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

NCT04956640

Conditions
Adnexal Diseases, Biliary Tract Diseases, Biliary Tract Neoplasms, +36 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • USC Norris Cancer Hospital Los Angeles, California, United States
  • Chao Family Comprehensive Cancer Ctr. Orange, California, United States
  • Yale-New Haven Hospital New Haven, Connecticut, United States
View all 49 locations
View Trial Details
Active, not recruiting

A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

NCT05094336

Conditions
Advanced MTAP-null Solid Tumors, Biliary Tract Diseases, Biliary Tract Neoplasms, +29 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • California Research Institute Glendale, California, United States
  • Fomat Medical Research Oxnard, California, United States
  • University of California at SF San Francisco, California, United States
View all 75 locations
View Trial Details
Active, not recruiting

Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).

NCT06333951

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Duarte, California, United States
  • Translational Research in Oncology US Inc, Trio Central Pharmacy Los Angeles, California, United States
View all 83 locations
View Trial Details
Active, not recruiting

Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)

NCT05882734

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • UCLA Hematology and Oncology - Santa Monica Santa Monica, California, United States
  • UPMC Cancer Center Pittsburgh, Pennsylvania, United States
  • Tennessee Cancer Specialists - Biomedical Research Knoxville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 54 locations
View Trial Details
Active, not recruiting

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

NCT04514484

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
View Trial Details
Active, not recruiting

CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia

NCT05887011

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Arkhangelsk, Russia
  • Research Site Balashikha, Russia
  • Research Site Barnaul, Russia
  • Research Site Grozny, Russia
View all 37 locations
View Trial Details
Active, not recruiting

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

NCT02568267

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +91 more
Locations
  • Dignity Health St Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope Duarte - Comprehensive Cancer Center, Investigational Drug Services Duarte, California, United States
View all 130 locations
View Trial Details

Related conditions